Bicarbonate vs Heparin Catheter Lock in Chronic Hemodialysis Patients
Status:
Active, not recruiting
Trial end date:
2020-09-28
Target enrollment:
Participant gender:
Summary
Prospective clinical trial to evaluate the efficacy of catheter lock with bicarbonate vs
heparin in chronic hemodialysis patients. Two groups will be created, sodium bicarbonate lock
group (experimental group) and heparin lock group (control group). Catheter pressures, flow,
patency and infection outcomes will be compare between groups at different time points (30,
60 and 90 days).
Phase:
Phase 4
Details
Lead Sponsor:
Hospital General "Dr. Miguel Silva" de Morelia Hospital General “Dr. Miguel Silva” de Morelia
Collaborators:
NAUSLIFE HEMODIALYSIS CLINICS Universidad Nacional Autonoma de Mexico